National Library of Medicine and 24 other accounts
Schedules
TAFS: 075-0807 /2024 - National Library of Medicine
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $493,548,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$9,919,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $9,919,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$2,234,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $80,100,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $571,414,000 | ||
| 6001 | Category A -- 1st quarter | $179,047,752 | ||
| 6002 | Category A -- 2nd quarter | $116,928,204 | ||
| 6003 | Category A -- 3rd quarter | $225,438,044 | ||
| 6004 | Category A -- 4th quarter | $50,000,000 | ||
| 6190 | Total budgetary resources available | $571,414,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0807 2024/2025 - National Library of Medicine
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $4,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $4,000,000 | ||
| 6001 | Category A -- 1st quarter | $1,366,000 | ||
| 6002 | Category A -- 2nd quarter | $863,600 | ||
| 6003 | Category A -- 3rd quarter | $1,270,400 | ||
| 6004 | Category A -- 4th quarter | $500,000 | ||
| 6190 | Total budgetary resources available | $4,000,000 |
TAFS: 075-0819 /2024 - John E. Fogarty International Center
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $95,162,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$25,951,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $25,951,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$32,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $13,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $108,130,000 | ||
| 6001 | Category A -- 1st quarter | $34,202,123 | ||
| 6002 | Category A -- 2nd quarter | $20,545,475 | ||
| 6003 | Category A -- 3rd quarter | $37,488,671 | ||
| 6004 | Category A -- 4th quarter | $15,893,731 | ||
| 6190 | Total budgetary resources available | $108,130,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0843 /2024 - National Institute on Aging
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $4,507,623,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$24,071,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $24,071,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $4,467,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $20,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $4,532,090,000 | ||
| 6001 | Category A -- 1st quarter | $1,509,411,254 | ||
| 6002 | Category A -- 2nd quarter | $959,805,806 | ||
| 6003 | Category A -- 3rd quarter | $1,562,872,940 | ||
| 6004 | Category A -- 4th quarter | $500,000,000 | ||
| 6190 | Total budgetary resources available | $4,532,090,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0844 /2024 - Eunice Kennedy Shriver National Institute of Child Health and Hu
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $1,759,078,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$154,175,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $154,175,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$1,294,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $38,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $1,795,784,000 | ||
| 6001 | Category A -- 1st quarter | $605,160,837 | ||
| 6002 | Category A -- 2nd quarter | $388,295,941 | ||
| 6003 | Category A -- 3rd quarter | $401,163,611 | ||
| 6004 | Category A -- 4th quarter | $401,163,611 | ||
| 6190 | Total budgetary resources available | $1,795,784,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0846 /2024 - Office of the Director
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $2,592,914,000 | ||
| 1101 | BA: Disc: Appropriation (special or trust) | $12,600,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$149,344,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $149,344,000 | ||
| 1151 | 1 | BA: Disc: Appropriations:Antic nonexpend trans net | -$3,089,000 | See footnotes below |
| Footnotes for line 1151 (1): | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1151 | 2 | BA: Disc: Appropriations:Antic nonexpend trans net | -$5,000,000 | See footnotes below |
| Footnotes for line 1151 (2): | B2: Pursuant to P.L. 118-47, $5,000,000 shall be transferred to Health and Human Services (HHS) "Office of Inspector General"(OIG) | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $125,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,722,425,000 | ||
| 6001 | Category A -- 1st quarter | $964,553,367 | ||
| 6002 | Category A -- 2nd quarter | $582,425,633 | ||
| 6003 | Category A -- 3rd quarter | $999,294,264 | ||
| 6004 | Category A -- 4th quarter | $176,151,736 | ||
| 6190 | Total budgetary resources available | $2,722,425,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0849 /2024 - National Cancer Institute
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $7,224,159,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$259,652,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $259,652,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$2,918,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $70,200,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $7,291,441,000 | ||
| 6001 | Category A -- 1st quarter | $2,443,713,143 | ||
| 6002 | Category A -- 2nd quarter | $1,561,085,084 | ||
| 6003 | Category A -- 3rd quarter | $2,125,100,000 | ||
| 6004 | Category A -- 4th quarter | $1,161,542,773 | ||
| 6190 | Total budgetary resources available | $7,291,441,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0851 /2024 - National Institute of General Medical Sciences
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $1,832,197,000 | ||
| 1701 | BA: Disc: Spending auth: Chng uncoll pymts Fed src | $1,412,482,000 | ||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $5,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $3,249,679,000 | ||
| 6001 | Category A -- 1st quarter | $809,819,666 | ||
| 6002 | Category A -- 2nd quarter | $882,940,883 | ||
| 6003 | Category A -- 3rd quarter | $1,313,732,841 | ||
| 6004 | Category A -- 4th quarter | $243,185,610 | ||
| 6190 | Total budgetary resources available | $3,249,679,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0862 /2024 - National Institute of Environmental Health Sciences
| Line # | Split | Description | Iteration 1 Previously Approved Amount | Iteration 2 Current OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1100 | 1 | BA: Disc: Appropriation | Line added— | +$913,979,000 $913,979,000 | |
| 1100 | BA: Disc: Appropriation | $79,714,000 | -$79,714,000 Line removed— | ||
| 1100 | 2 | BA: Disc: Appropriation | Line added— | +$79,714,000 $79,714,000 | |
| 1120 | BA: Disc: Approps transferred to other accounts | Line added— | -$5,684,000 -$5,684,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | Line added— | +$5,684,000 $5,684,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | Line added— | -$172,000 -$172,000 | See footnotes below | |
| Footnotes for line 1151 (Current): | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | ||||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $4,000,000 | +$12,000,000 $16,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $83,714,000 | +$925,807,000 $1,009,521,000 | ||
| 6001 | Category A -- 1st quarter | Line added— | +$315,137,029 $315,137,029 | ||
| 6002 | Category A -- 2nd quarter | Line added— | +$200,019,666 $200,019,666 | ||
| 6003 | Category A -- 3rd quarter | Line added— | +$318,069,605 $318,069,605 | ||
| 6004 | Category A -- 4th quarter | Line added— | +$92,580,700 $92,580,700 | ||
| 6011 | Superfund | $83,714,000 | $83,714,000 | ||
| 6190 | Total budgetary resources available | $83,714,000 | +$925,807,000 $1,009,521,000 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
| Footnotes for line 6190 (Current): | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
TAFS: 075-0872 /2024 - National Heart, Lung, and Blood Institute
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $3,982,345,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$90,140,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $90,140,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $2,813,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $30,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $4,015,158,000 | ||
| 6001 | Category A -- 1st quarter | $1,365,905,818 | ||
| 6002 | Category A -- 2nd quarter | $874,795,286 | ||
| 6003 | Category A -- 3rd quarter | $1,200,000,000 | ||
| 6004 | Category A -- 4th quarter | $574,456,896 | ||
| 6190 | Total budgetary resources available | $4,015,158,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0873 /2024 - National Institute of Dental and Craniofacial Research
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $520,163,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$20,199,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $20,199,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$25,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $4,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $524,138,000 | ||
| 6001 | Category A -- 1st quarter | $181,635,664 | ||
| 6002 | Category A -- 2nd quarter | $112,303,192 | ||
| 6003 | Category A -- 3rd quarter | $155,000,000 | ||
| 6004 | Category A -- 4th quarter | $75,199,144 | ||
| 6190 | Total budgetary resources available | $524,138,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0875 /2024 - National Center for Advancing Translational Sciences
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $928,323,000 | ||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $65,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $993,323,000 | ||
| 6001 | Category A -- 1st quarter | $331,636,304 | ||
| 6002 | Category A -- 2nd quarter | $216,334,936 | ||
| 6003 | Category A -- 3rd quarter | $345,351,760 | ||
| 6004 | Category A -- 4th quarter | $100,000,000 | ||
| 6190 | Total budgetary resources available | $993,323,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0884 /2024 - National Institute of Diabetes and Digestive and Kidney Diseases
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $2,310,721,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$36,322,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $36,322,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $2,377,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $8,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,321,098,000 | ||
| 6001 | Category A -- 1st quarter | $787,696,221 | ||
| 6002 | Category A -- 2nd quarter | $498,873,464 | ||
| 6003 | Category A -- 3rd quarter | $600,000,000 | ||
| 6004 | Category A -- 4th quarter | $434,528,315 | ||
| 6190 | Total budgetary resources available | $2,321,098,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0885 /2024 - National Institute of Allergy and Infectious Diseases
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $6,562,279,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$1,911,991,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $1,911,991,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$627,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $40,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $6,601,652,000 | ||
| 6001 | Category A -- 1st quarter | $2,254,678,279 | ||
| 6002 | Category A -- 2nd quarter | $1,420,624,036 | ||
| 6003 | Category A -- 3rd quarter | $2,000,000,000 | ||
| 6004 | Category A -- 4th quarter | $926,349,685 | ||
| 6190 | Total budgetary resources available | $6,601,652,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0886 /2024 - National Institute of Neurological Disorders and Stroke
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $2,603,925,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$45,713,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $45,713,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$4,507,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $42,350,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,641,768,000 | ||
| 6001 | Category A -- 1st quarter | $894,117,888 | ||
| 6002 | Category A -- 2nd quarter | $575,528,908 | ||
| 6003 | Category A -- 3rd quarter | $644,167,600 | ||
| 6004 | Category A -- 4th quarter | $527,953,604 | ||
| 6190 | Total budgetary resources available | $2,641,768,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0887 /2024 - National Eye Institute
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $896,549,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$413,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $413,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$413,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $25,100,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $921,236,000 | ||
| 6001 | Category A -- 1st quarter | $331,271,484 | ||
| 6002 | Category A -- 2nd quarter | $193,564,929 | ||
| 6003 | Category A -- 3rd quarter | $305,227,682 | ||
| 6004 | Category A -- 4th quarter | $91,171,905 | ||
| 6190 | Total budgetary resources available | $921,236,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0888 /2024 - National Institute Arthritis and Musculoskeletal and Skin Diseas
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $685,465,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$2,701,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $2,701,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $2,174,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $15,035,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $702,674,000 | ||
| 6001 | Category A -- 1st quarter | $237,864,872 | ||
| 6002 | Category A -- 2nd quarter | $152,491,894 | ||
| 6003 | Category A -- 3rd quarter | $199,889,394 | ||
| 6004 | Category A -- 4th quarter | $112,427,840 | ||
| 6190 | Total budgetary resources available | $702,674,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0889 /2024 - National Institute of Nursing Research
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $197,693,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$17,397,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $17,397,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$22,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $2,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $199,671,000 | ||
| 6001 | Category A -- 1st quarter | $67,974,359 | ||
| 6002 | Category A -- 2nd quarter | $42,681,919 | ||
| 6003 | Category A -- 3rd quarter | $54,014,722 | ||
| 6004 | Category A -- 4th quarter | $35,000,000 | ||
| 6190 | Total budgetary resources available | $199,671,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0890 /2024 - National Institute on Deafness and Other Communication Disorders
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $534,333,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$2,265,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $2,265,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$3,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $2,500,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $536,830,000 | ||
| 6001 | Category A -- 1st quarter | $182,802,469 | ||
| 6002 | Category A -- 2nd quarter | $116,512,495 | ||
| 6003 | Category A -- 3rd quarter | $187,000,036 | ||
| 6004 | Category A -- 4th quarter | $50,515,000 | ||
| 6190 | Total budgetary resources available | $536,830,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0891 /2024 - National Human Genome Research Institute
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $663,200,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$3,514,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $3,514,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$3,514,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $37,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $696,686,000 | ||
| 6001 | Category A -- 1st quarter | $241,482,800 | ||
| 6002 | Category A -- 2nd quarter | $153,184,880 | ||
| 6003 | Category A -- 3rd quarter | $248,067,000 | ||
| 6004 | Category A -- 4th quarter | $53,951,320 | ||
| 6190 | Total budgetary resources available | $696,686,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0892 /2024 - National Institute of Mental Health
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $2,187,843,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$195,774,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $195,774,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $3,810,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $10,050,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,201,703,000 | ||
| 6001 | Category A -- 1st quarter | $723,853,439 | ||
| 6002 | Category A -- 2nd quarter | $464,773,019 | ||
| 6003 | Category A -- 3rd quarter | $863,076,542 | ||
| 6004 | Category A -- 4th quarter | $150,000,000 | ||
| 6190 | Total budgetary resources available | $2,201,703,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0893 /2024 - National Institute on Drug Abuse
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $1,662,695,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$277,863,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $277,863,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $670,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $18,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $1,681,365,000 | ||
| 6001 | Category A -- 1st quarter | $582,810,343 | ||
| 6002 | Category A -- 2nd quarter | $358,975,851 | ||
| 6003 | Category A -- 3rd quarter | $630,204,403 | ||
| 6004 | Category A -- 4th quarter | $109,374,403 | ||
| 6190 | Total budgetary resources available | $1,681,365,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0894 /2024 - National Institute on Alcohol Abuse and Alcoholism
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $595,318,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$33,921,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $33,921,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $1,798,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $7,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $604,116,000 | ||
| 6001 | Category A -- 1st quarter | $206,001,097 | ||
| 6002 | Category A -- 2nd quarter | $130,829,157 | ||
| 6003 | Category A -- 3rd quarter | $133,642,873 | ||
| 6004 | Category A -- 4th quarter | $133,642,873 | ||
| 6190 | Total budgetary resources available | $604,116,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0896 /2024 - National Center for Complementary and Integrative Health
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $170,384,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$796,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $796,000 | ||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $6,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $176,384,000 | ||
| 6001 | Category A -- 1st quarter | $58,972,736 | ||
| 6002 | Category A -- 2nd quarter | $38,285,906 | ||
| 6003 | Category A -- 3rd quarter | $54,125,358 | ||
| 6004 | Category A -- 4th quarter | $25,000,000 | ||
| 6190 | Total budgetary resources available | $176,384,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0897 /2024 - National Institute on Minority Health and Health Disparities
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $534,395,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$24,239,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $24,239,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $743,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $6,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $541,138,000 | ||
| 6001 | Category A -- 1st quarter | $181,129,893 | ||
| 6002 | Category A -- 2nd quarter | $114,840,281 | ||
| 6003 | Category A -- 3rd quarter | $200,457,160 | ||
| 6004 | Category A -- 4th quarter | $44,710,666 | ||
| 6190 | Total budgetary resources available | $541,138,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
TAFS: 075-0898 /2024 - National Institute of Biomedical Imaging and Bioengineering
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $440,627,000 | ||
| 1120 | BA: Disc: Approps transferred to other accounts | -$1,956,000 | ||
| 1121 | BA: Disc: Approps transferred from other accounts | $1,956,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$2,000 | See footnotes below | |
| Footnotes for line 1151: | B1: Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $15,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $455,625,000 | ||
| 6001 | Category A -- 1st quarter | $154,158,692 | ||
| 6002 | Category A -- 2nd quarter | $96,576,066 | ||
| 6003 | Category A -- 3rd quarter | $140,475,731 | ||
| 6004 | Category A -- 4th quarter | $64,414,511 | ||
| 6190 | Total budgetary resources available | $455,625,000 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| B1 | Reflects amount transferred pursuant to Section 213 of the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) relating to the NIH HIV/AIDS transfer. |
| B2 | Pursuant to P.L. 118-47, $5,000,000 shall be transferred to Health and Human Services (HHS) "Office of Inspector General"(OIG) |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.